Pharma News

Looking out for latest news on Pharma Magazine?
Check out the latest Pharma news, Top news in Pharma Magazine, Leading Magazine in Pharma industry. Daily news updates pertinent to the industrial sectors we are engaged with are depicted on the news section of Pharma industry which we operate.

Asahi Kasei Medical to Acquire Bionova Scientific, U.S.-based Biopharmaceutical CDMO

Tuesday, April 19, 2022

Asahi Kasei Medical concluded an agreement on April JST through a US subsidiary to wholly acquire Bionova Scientific LLC a provider of contract process development services and GMPcompliant contract manufacturing services to biopharmaceutical compa...

Ankyra Therapeutics Announces Cooperative Research and Development Agreement with the National Cancer Institute

Monday, April 18, 2022

Ankyra Therapeutics is pleased to announce that it has established a formal Cooperative Research and Development Agreement with the National Cancer Institute NCI to pursue basic translational and clinical research using Ankyra Therapeutics emerging a...

Halozyme to Acquire Antares Pharma to Create a Specialty Product and Drug Delivery Leader

Thursday, April 14, 2022

Halozyme Therapeutics Inc and Antares Pharma Inc announced that the companies have entered into a definitive agreement pursuant to which Halozyme will acquire Antares for per share in cash The transaction which values Antares at approximately milli...

ATyr Pharma Announces FDA Orphan Drug Designation for Efzofitimod (ATYR1923) for Treatment of Systemic Sclerosis

Thursday, April 14, 2022

ATyr Pharma Inc a clinical stage biotherapeutics company engaged in the discovery and development of innovative medicines based on novel biological pathways today announced that the US Food and Drug Administration FDA has granted the company orphan d...

Persephone Biosciences and Ginkgo Bioworks Announce Collaboration to Develop Novel Therapeutics

Wednesday, April 13, 2022

Persephone Biosciences Inc a synthetic biology company reimagining patient and infant health and Ginkgo Bioworks the leading horizontal platform for cell programming today announced a collaboration to develop a novel therapeutics based on the bacteri...

Achilles Therapeutics Announces Manufacturing Expansion in the UK and Partnership for Manufacturing in the US

Wednesday, April 13, 2022

Achilles Therapeutics plc a clinicalstage biopharmaceutical company developing precision T cell therapies to treat solid tumors today announced clinical manufacturing expansion in the United Kingdom UK and the United States US Achilles manufacturing...

Bioasis Enters Into Research Collaboration With Janssen

Tuesday, April 12, 2022

Bioasis Technologies Inc a biopharmaceutical company developing its proprietary xBTM platform technology for the delivery of therapeutics across the bloodbrain barrier the BBB announced today that it has entered into a research collaboration with Jan...

Telix Announces Licence Agreement with Lilly for Olaratumab

Tuesday, April 12, 2022

Telix announces a licence agreement for Lillys olaratumab antibody for diagnosis and treatment of human cancers Telix is pleased to announce that it has entered into a licence agreement with Eli Lilly and Company Lilly under which Telix is granted ex...

SciRhom Starts CMC Development of its First Drug Candidate for Clinical Development

Monday, April 11, 2022

SciRhom GmbH announced today that it has nominated the antiiRhom antibody it will advance into clinical development For this antibody the company has closed an agreement with a toptier biopharmaceutical manufacturer for the CMC development This first...

Revive Therapeutics Provides Update on Phase 3 Clinical Trial for Bucillamine in COVID-19

Monday, April 11, 2022

Revive Therapeutics Ltd a specialty life sciences company focused on the research and development of therapeutics for medical needs and rare disorders is pleased to provide an update on the Companys US Food Drug Administration FDA Phase clinical tr...